Emma Yasinski's profile photo

Emma Yasinski

Science Journalist at Freelance

Freelance science journalist. Words at @undarkmag @natgeo, @nytimeswell & more. Find me on TikTok: https://t.co/B8APMjTIz2

Featured in: Favicon uol.com.br Favicon medium.com Favicon nytimes.com Favicon time.com Favicon nationalgeographic.com Favicon npr.org Favicon theatlantic.com Favicon vice.com Favicon yahoo.com (+5) Favicon arstechnica.com

Articles

  • Forever Chemicals: The Link Between PFAS and Dementia

    1 week ago | news.med.miami.edu | Emma Yasinski

    By: Emma Yasinski | June 02, 2025 | 8 min. read |  Share SummaryThe Miller School’s Dr. Hannah Gardener is studying the impact of PFAS on brain health.

  • INVESTIGATING GENERICS: They Say Their ADHD Meds Aren't Working. They're Not Imagining It - MedShadow Foundation

    2 weeks ago | medshadow.org | Emma Yasinski

    Fact Checked FACT CHECKED The first time Marilynn Monroe took Adderall (a combination of amphetamine and dextroamphetamine) for her ADHD, she says she cried tears of joy. She was 15 years old. “The symptoms that were holding me back from living a semi-normal life [started with], obviously, the inability to focus,” she says. “But it was so much more than that.

  • Base Editing Brings Scientists Closer to Treating Mitochondrial Disease

    1 month ago | news.med.miami.edu | Emma Yasinski

    By: Emma Yasinski | May 01, 2025 | 6 min. read |  Share SummaryDr. Jose Barrera-Paez published a study in Science Translation Medicine discussing a base editing technique to treat mitochondrial disease. The study found that base editing remains imprecise and at higher doses it can introduce detrimental errors.

  • The Risks and Genetics of Alzheimer’s Disease

    1 month ago | news.med.miami.edu | Emma Yasinski

    By: Emma Yasinski | April 29, 2025 | 12 min. read |  Share SummaryResearchers from the John P. Hussman Institute for Human Genomics presented research findings illuminating the complex biology of Alzheimer’s disease at the recent Alzheimer’s Disease/Parkinson’s Disease annual meeting.

  • Sylvester Researchers Study Quality of Life During Immunotherapy Treatment

    Mar 12, 2025 | news.med.miami.edu | Emma Yasinski

    By: Emma Yasinski | March 12, 2025 | 8 min. read |  Share SummaryImmune checkpoint inhibitors have been a game-changer in oncology but have unique side effects for patients. A Sylvester researcher team is using a National Cancer Institute grant to investigate the nature of immune checkpoint inhibitor side effects.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
723
Tweets
1K
DMs Open
Yes
Emma Yasinski
Emma Yasinski @EmmaYas24
19 Mar 25

RT @HistoryNevada: Pioneer of methadone treatment for heroine addicts and author of "The Drug Addict as a Patient," psychiatrist Dr Marie N…

Emma Yasinski
Emma Yasinski @EmmaYas24
17 Mar 25

RT @EmmaYas24: Do you take medicine to manage #ADHD? Have you experienced side effects or differences in efficacy month to month? Do you su…

Emma Yasinski
Emma Yasinski @EmmaYas24
14 Mar 25

Do you take medicine to manage #ADHD? Have you experienced side effects or differences in efficacy month to month? Do you suspect it was due to a bad batch of medicine or a change in manufacturers? I'd love to talk to you for a story. #journorequest #medicine #Psychiatry